Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer, April 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 188 articles:
HTML format


 

Single Articles

  1. ZHANG L, Liu Y, Zheng P
    Downregulation of ADAMTS18 May Serve as a Poor Prognostic Biomarker for Cervical Cancer Patients.
    Appl Immunohistochem Mol Morphol. 2017 Mar 30. doi: 10.1097/PAI.0000000000000496
    Abstract    

    Abstract available

  2. HAMERS FF, Duport N, Beltzer N
    Population-based organized cervical cancer screening pilot program in France.
    Eur J Cancer Prev. 2017 Mar 30. doi: 10.1097/CEJ.0000000000000365.
    Abstract    

    Abstract available

  3. LI Y, Ho Kang M, Sup Uhm H, Joon Lee G, et al
    Effects of atmospheric-pressure non-thermal bio-compatible plasma and plasma activated nitric oxide water on cervical cancer cells.
    Sci Rep. 2017;7:45781.
    Abstract    

    Abstract available

  4. SATINDER K, Sobti RC, Pushpinder K
    Impact of single nucleotide polymorphism in chemical metabolizing genes and exposure to wood smoke on risk of cervical cancer in North-Indian women.
    Exp Oncol. 2017;39:69-74.
    Abstract    

    Abstract available

  5. LEE TH, Kim W, Shin J, Park EC, et al
    Strategic Distributional Cost-Effectiveness Analysis for Improving National Cancer Screening Uptake in Cervical Cancer: A Focus on Regional Inequality in South Korea.
    Cancer Res Treat. 2017 Mar 30. doi: 10.4143/crt.2016.
    Abstract    

    Abstract available

  6. RUTA K, Jolita R, Ingrida L, Nadezda L, et al
    Increasing attendance in a cervical cancer screening programme by personal invitation: experience of a Lithuanian primary health care centre.
    Acta Med Litu. 2016;23:180-184.
    Abstract    

    Abstract available

  7. TAGUCHI Y, Horiuchi Y, Kano F, Murata M, et al
    Novel prosurvival function of Yip1A in human cervical cancer cells: constitutive activation of the IRE1 and PERK pathways of the unfolded protein response.
    Cell Death Dis. 2017;8:e2718.
    Abstract    

    Abstract available

  8. KIM SW, Chun M, Ryu HS, Chang SJ, et al
    Salvage radiotherapy with or without concurrent chemotherapy for pelvic recurrence after hysterectomy alone for early-stage uterine cervical cancer.
    Strahlenther Onkol. 2017 Mar 29. doi: 10.1007/s00066-017-1122.
    Abstract    

    Abstract available

  9. PHUAH NH, Azmi MN, Awang K, Nagoor NH, et al
    Suppression of microRNA-629 enhances sensitivity of cervical cancer cells to 1'S-1'-acetoxychavicol acetate via regulating RSU1.
    Onco Targets Ther. 2017;10:1695-1705.
    Abstract    

    Abstract available

  10. BRAZ NS, Lorenzi NP, Sorpreso IC, Aguiar LM, et al
    The acceptability of vaginal smear self-collection for screening for cervical cancer: a systematic review.
    Clinics (Sao Paulo). 2017;72:183-187.
    Abstract    

    Abstract available

  11. LI M, Feng YM, Fang SQ
    Overexpression of ezrin and galectin-3 as predictors of poor prognosis of cervical cancer.
    Braz J Med Biol Res. 2017;50:e5356.
    Abstract    

    Abstract available

  12. OBIRI-YEBOAH D, Adu-Sarkodie Y, Djigma F, Akakpo K, et al
    Erratum to: Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana.
    Gynecol Oncol Res Pract. 2017;4:8.
    Abstract    

    Abstract available

  13. ZHANG SA, Niyazi HE, Hong W, Tuluwengjiang GL, et al
    Effect of EBI3 on radiation-induced immunosuppression of cervical cancer HeLa cells by regulating Treg cells through PD-1/PD-L1 pathway.
    Tumour Biol. 2017;39:1010428317692237.
    Abstract    

    Abstract available

  14. BHAT S, Kabekkodu SP, Varghese VK, Chakrabarty S, et al
    Aberrant gene-specific DNA methylation signature analysis in cervical cancer.
    Tumour Biol. 2017;39:1010428317694573.
    Abstract    

    Abstract available

  15. TIEZZI DG
    Future Perspectives for Uterine Cervical Cancer Treatment based on Integrative Genomic and Molecular Characterizations.
    Rev Bras Ginecol Obstet. 2017 Mar 28. doi: 10.1055/s-0037-1601399.
    Abstract    



  16. LECHANTEUR A, Furst T, Evrard B, Delvenne P, et al
    Promoting vaginal distribution of E7 and MCL-1 siRNA-silencing nanoparticles for cervical cancer treatment.
    Mol Pharm. 2017 Mar 28. doi: 10.1021/acs.molpharmaceut.6b01154.
    Abstract    

    Abstract available

  17. SU K, Wang CF, Zhang Y, Cai YJ, et al
    miR-940 upregulation contributes to human cervical cancer progression through p27 and PTEN inhibition.
    Int J Oncol. 2017 Mar 7. doi: 10.3892/ijo.2017.3897.
    Abstract    

    Abstract available

  18. SINGH MB, Harrington AT
    Pasteurella multocida urinary tract infection in a patient with cervical cancer.
    JMM Case Rep. 2017;4:e005082.
    Abstract    

    Abstract available

  19. PRASONGVEJ P, Nanthakomon T, Jaisin K, Chanthasenanont A, et al
    Quality of Life in Cervical Cancer Survivors and Healthy Women: Thai Urban Population Study
    Asian Pac J Cancer Prev. 2017;18:385-389.
    Abstract    

    Abstract available

  20. REFAEI M, Dehghan Nayeri N, Khakbazan Z, Pakgohar M, et al
    Cervical Cancer Screening in Iranian Women: Healthcare Practitioner Perceptions and Views
    Asian Pac J Cancer Prev. 2017;18:357-363.
    Abstract    

    Abstract available

  21. YEON J, Jung YW, Yang SS, Kang BH, et al
    Lower limb compartment syndrome by reperfusion injury after treatment of arterial thrombosis post-laparoscopic radical hysterectomy and pelvic lymph node dissection for cervical cancer.
    Obstet Gynecol Sci. 2017;60:223-226.
    Abstract    

    Abstract available

  22. VAN MEIR H, Nout RA, Welters MJ, Loof NM, et al
    Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients.
    Oncoimmunology. 2016;6:e1267095.
    Abstract    

    Abstract available

  23. BALSAT C, Blacher S, Herfs M, Van de Velde M, et al
    A specific immune and lymphatic profile characterizes the pre-metastatic state of the sentinel lymph node in patients with early cervical cancer.
    Oncoimmunology. 2017;6:e1265718.
    Abstract    

    Abstract available

  24. KARLSSON L, Thunberg P, With A, Mordhorst LB, et al
    3D image-based adapted high-dose-rate brachytherapy in cervical cancer with and without interstitial needles: measurement of applicator shift between imaging and dose delivery.
    J Contemp Brachytherapy. 2017;9:52-58.
    Abstract    

    Abstract available

  25. KESSLER TA
    Cervical Cancer: Prevention and Early Detection.
    Semin Oncol Nurs. 2017 Mar 23. pii: S0749-2081(17)30015.
    Abstract    

    Abstract available

  26. LEE H, Kim M, Allison J, Kiang P, et al
    Development of a theory-guided storytelling narrative intervention to improve HPV vaccination behavior: Save our daughters from cervical cancer.
    Appl Nurs Res. 2017;34:57-61.
    Abstract    



  27. NIU G, Wang D, Pei Y, Sun L, et al
    Systematic identification of key genes and pathways in the development of invasive cervical cancer.
    Gene. 2017 Mar 21. pii: S0378-1119(17)30176-2. doi: 10.1016/j.gene.2017.
    Abstract    

    Abstract available

  28. ALVAREZ-OLMEDO DG, Biaggio VS, Koumbadinga GA, Gomez NN, et al
    Recombinant heat shock protein 27 (HSP27/HSPB1) protects against cadmium-induced oxidative stress and toxicity in human cervical cancer cells.
    Cell Stress Chaperones. 2017 Mar 24. doi: 10.1007/s12192-017-0768.
    Abstract    

    Abstract available

  29. CHATZISTAMATIOU K, Moysiadis T, Angelis E, Kaufmann A, et al
    Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
    Arch Gynecol Obstet. 2017 Mar 23. doi: 10.1007/s00404-017-4324.
    Abstract    

    Abstract available

  30. MAZA M, Alfaro K, Garai J, Velado MM, et al
    Cervical cancer prevention in El Salvador (CAPE)-An HPV testing-based demonstration project: Changing the secondary prevention paradigm in a lower middle-income country.
    Gynecol Oncol Rep. 2017;20:58-61.
    Abstract    

    Abstract available

  31. LI J, Meng X, Hu J, Zhang Y, et al
    Heparanase promotes radiation resistance of cervical cancer by upregulating hypoxia inducible factor 1.
    Am J Cancer Res. 2017;7:234-244.
    Abstract    

    Abstract available

  32. LIN L, Zhao W, Sun B, Wang X, et al
    Overexpression of TRIM24 is correlated with the progression of human cervical cancer.
    Am J Transl Res. 2017;9:620-628.
    Abstract    

    Abstract available

  33. HOU J, Yang H, Huang X, Leng X, et al
    N-WASP promotes invasion and migration of cervical cancer cells through regulating p38 MAPKs signaling pathway.
    Am J Transl Res. 2017;9:403-415.
    Abstract    

    Abstract available

  34. TRIFILETTI DM, Grover S, Libby B, Showalter TN, et al
    Trends in cervical cancer brachytherapy volume suggest case volume is not the primary driver of poor compliance rates with brachytherapy delivery for locally advanced cervical cancer.
    Brachytherapy. 2017 Mar 20. pii: S1538-4721(17)30043.
    Abstract    

    Abstract available

  35. COSSAR LH, Schache AG, Risk JM, Sacco JJ, et al
    Modulating the DNA Damage Response to Improve Treatment Response in Cervical Cancer.
    Clin Oncol (R Coll Radiol). 2017 Mar 20. pii: S0936-6555(17)30119.
    Abstract    

    Abstract available

  36. CORDEIRO CN, Gemignani ML
    Gynecologic Malignancies in Pregnancy: Balancing Fetal Risks With Oncologic Safety.
    Obstet Gynecol Surv. 2017;72:184-193.
    Abstract    

    Abstract available

  37. SALEK G, Lalya I, Rahali DM, Dehayni M, et al
    Villoglandular papillary adenocarcinoma: case report.
    Pan Afr Med J. 2016;25:232.
    Abstract    

    Abstract available

  38. SAMLALI H, Jouhadi H, Attar H, Sahraoui S, et al
    [A rare cases of rhabdomyosarcoma of the uterine cervix: about a case and review of the literature].
    Pan Afr Med J. 2016;25:166.
    Abstract    

    Abstract available

  39. MEHTA AM, Mooij M, Brankovic I, Ouburg S, et al
    Cervical Carcinogenesis and Immune Response Gene Polymorphisms: A Review.
    J Immunol Res. 2017;2017:8913860.
    Abstract    

    Abstract available

  40. EISINGER F, Pivot X, Greillier L, Couraud S, et al
    [Cancer screening in France: 10 years of analysis of behaviours by the EDIFICE surveys].
    Bull Cancer. 2017;104:258-266.
    Abstract    

    Abstract available

  41. CORDEIRO JC, da Silva JS, Roxo VS, da Graca Bicalho M, et al
    A pilot study on Hla-G locus control region haplotypes and cervical intraepithelial neoplasias.
    Hum Immunol. 2017;78:281-286.
    Abstract    

    Abstract available

  42. YOUNG J, Yee M, Kim H, Cheung J, et al
    Phototoxicity of Liposomal Zn- and Al-phthalocyanine Against Cervical and Oral Squamous Cell Carcinoma Cells In Vitro.
    Med Sci Monit Basic Res. 2016;22:156-164.
    Abstract    

    Abstract available

  43. THANGAVELU PU, Krenacs T, Dray E, Duijf PH, et al
    In epithelial cancers, aberrant COL17A1 promoter methylation predicts its misexpression and increased invasion.
    Clin Epigenetics. 2016;8:120.
    Abstract    

    Abstract available

  44. SUNG W, Kim JI, Kim HS, Kim HJ, et al
    Performance of the irregular surface compensator compared with four-field box and intensity modulated radiation therapy for gynecologic cancer.
    Phys Med. 2016;32:1537-1542.
    Abstract    

    Abstract available

  45. MENG J, Zhu L, Zhu L, Wang H, et al
    Apparent diffusion coefficient histogram shape analysis for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy.
    Radiat Oncol. 2016;11:141.
    Abstract    

    Abstract available

  46. OZAWA N, Ito K, Tase T, Metoki H, et al
    Beneficial Effects of Human Papillomavirus Vaccine for Prevention of Cervical Abnormalities in Miyagi, Japan.
    Tohoku J Exp Med. 2016;240:147-151.
    Abstract    

    Abstract available

  47. ROB F, Tachezy R, Pichlik T, Rob L, et al
    High prevalence of genital HPV infection among long-term monogamous partners of women with cervical dysplasia or genital warts-Another reason for HPV vaccination of boys.
    Dermatol Ther. 2017;30.
    Abstract    

    Abstract available

  48. DIJKSTRA MG, van Zummeren M, Rozendaal L, van Kemenade FJ, et al
    Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
    BMJ. 2016;355:i4924.
    Abstract    

    Abstract available

  49. SEKI T, Tanabe H, Nagata C, Suzuki J, et al
    Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
    Jpn J Clin Oncol. 2017;47:32-38.
    Abstract    

    Abstract available

  50. MUPANDAWANA ET, Cross R
    Attitudes towards human papillomavirus vaccination among African parents in a city in the north of England: a qualitative study.
    Reprod Health. 2016;13:97.
    Abstract    

    Abstract available

  51. WANG H, Gao W
    DJ-1 Expression in Cervical Carcinoma and its Effects on Cell Viability and Apoptosis.
    Med Sci Monit. 2016;22:2943-9.
    Abstract    

    Abstract available

  52. GICHANE MW, Calo WA, McCarthy SH, Walmer KA, et al
    Human Papillomavirus Awareness in Haiti: Preparing for a National HPV Vaccination Program.
    J Pediatr Adolesc Gynecol. 2017;30:96-101.
    Abstract    

    Abstract available

  53. ERBAY G, Onal C, Karadeli E, Guler OC, et al
    Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images.
    Acta Radiol. 2017;58:481-488.
    Abstract    

    Abstract available

  54. SANTOS FILHO MV, Gurgel AP, Lobo CD, Freitas AC, et al
    Prevalence of human papillomavirus (HPV), distribution of HPV types, and risk factors for infection in HPV-positive women.
    Genet Mol Res. 2016;15.
    Abstract    

    Abstract available

  55. ZHANG JX, Wang SZ, Li B, Zhang ZY, et al
    [Clinical analysis of 23 gynecologic carcinoma patients with brain metastasis].
    Zhonghua Yi Xue Za Zhi. 2016;96:1843-6.
    Abstract    

    Abstract available

  56. O'REILLY FH, Shaw W
    A dosimetric evaluation of IGART strategies for cervix cancer treatment.
    Phys Med. 2016;32:1360-1367.
    Abstract    

    Abstract available

  57. MESERVE EE, Nucci MR
    Peutz-Jeghers Syndrome: Pathobiology, Pathologic Manifestations, and Suggestions for Recommending Genetic Testing in Pathology Reports.
    Surg Pathol Clin. 2016;9:243-68.
    Abstract    

    Abstract available

  58. ZUTSHI V, Makkar B, Garg A, Batra S, et al
    Transvaginal Sonography Versus Cystoscopy for Detecting Urinary Bladder Invasion in Early Stage Cervical Cancer.
    J Clin Diagn Res. 2017;11:QC01-QC03.
    Abstract    

    Abstract available

  59. LANDONI F, Colombo A, Milani R, Placa F, et al
    Randomized study between radical surgery and radiotherapy for the treatment of stage IB-IIA cervical cancer: 20-year update.
    J Gynecol Oncol. 2017.
    Abstract    

    Abstract available

  60. LIM MC, Lee M, Shim SH, Nam EJ, et al
    Practice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement.
    J Gynecol Oncol. 2017.
    Abstract    

    Abstract available

  61. WANG W, Shang CL, Du QQ, Wu D, et al
    Class I versus Class III radical hysterectomy in stage IB1 (tumor </= 2 cm) cervical cancer: a matched cohort study.
    J Cancer. 2017;8:825-831.
    Abstract    

    Abstract available

  62. YUAN H, Krawczyk E, Blancato J, Albanese C, et al
    HPV positive neuroendocrine cervical cancer cells are dependent on Myc but not E6/E7 viral oncogenes.
    Sci Rep. 2017;7:45617.
    Abstract    

    Abstract available

  63. YANG H, Yang M, Wang Y, Huang X, et al
    Note of clarification of data in the paper entitled "Interferon gamma +874 T/A polymorphism increases the risk of cervical cancer: evidence from a meta-analysis".
    Tumour Biol. 2017;39:1010428317694564.
    Abstract    

    Abstract available

  64. CHEN TH, Yang SF, Liu YF, Lin WL, et al
    Association of Fibroblast Growth Factor Receptor 4 Genetic Polymorphisms With the Development of Uterine Cervical Cancer and Patient Prognosis.
    Reprod Sci. 2017 Jan 1:1933719117702250. doi: 10.1177/1933719117702250.
    Abstract    

    Abstract available

  65. WU Q, Zhao X, Fu Y, Wang X, et al
    A cross-sectional study on HPV testing with type 16/18 genotyping for cervical cancer screening in 11,064 Chinese women.
    Cancer Med. 2017 Apr 4. doi: 10.1002/cam4.1060.
    Abstract    

    Abstract available

  66. KIM JJ, Burger EA, Sy S, Campos NG, et al
    Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.
    J Natl Cancer Inst. 2017;109:1-9.
    Abstract    

    Abstract available

  67. LAMB RL, Ramos Jaraba SM, Graciano Tangarife V, Garces-Palacio IC, et al
    Evaluation of Entertainment Education Strategies to Promote Cervical Cancer Screening and Knowledge in Colombian Women.
    J Cancer Educ. 2017 Apr 4. doi: 10.1007/s13187-017-1213.
    Abstract    

    Abstract available

  68. LIU C, Wang J, Hu Y, Xie H, et al
    Upregulation of kazrin F by miR-186 suppresses apoptosis but promotes epithelial-mesenchymal transition to contribute to malignancy in human cervical cancer cells.
    Chin J Cancer Res. 2017;29:45-56.
    Abstract    

    Abstract available

  69. CHANG HK, Myong JP, Byun SW, Lee SJ, et al
    Factors associated with participation in cervical cancer screening among young Koreans: a nationwide cross-sectional study.
    BMJ Open. 2017;7:e013868.
    Abstract    

    Abstract available

  70. CAMPOS NG, Tsu V, Jeronimo J, Njama-Meya D, et al
    Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting.
    Health Policy Plan. 2017 Feb 20. doi: 10.1093.
    Abstract    

    Abstract available

  71. MAURA G, Chaignot C, Weill A, Alla F, et al
    Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study.
    Eur J Cancer Prev. 2017 Mar 31. doi: 10.1097/CEJ.0000000000000360.
    Abstract    

    Abstract available

  72. NAUMOVIC T, Lakic V, Jovicevic A, Ilic D, et al
    New software for collecting data from the organized cervical cancer screening program in Serbia. Are we on the threshold of a new screening registry? - A multicentric study.
    J BUON. 2017;22:58-63.
    Abstract    

    Abstract available

  73. MILENKOVIC M, Naumovic T, Perisic Z, Milenkovic D, et al
    Organised cervical cancer screening programme in the Belgrade municipality of Cukarica - Evaluation of process indicators.
    J BUON. 2017;22:44-47.
    Abstract    

    Abstract available

  74. LIU Y, Zhang L, Zhao G, Che L, et al
    The clinical research of Thinprep Cytology Test (TCT) combined with HPV-DNA detection in screening cervical cancer.
    Cell Mol Biol (Noisy-le-grand). 2017;63:92-95.
    Abstract    

    Abstract available

  75. CHEN X, Lan K, Liu Q, Yang X, et al
    Sulfiredoxin may promote metastasis and invasion of cervical squamous cell carcinoma by epithelial-mesenchymal transition.
    Tumour Biol. 2017;39:1010428317695942.
    Abstract    

    Abstract available

  76. GAO G, Smith DI
    Human Papillomavirus and the Development of Different Cancers.
    Cytogenet Genome Res. 2016;150.
    Abstract    

    Abstract available

  77. SOPRACORDEVOLE F, Clemente N, Alessandrini L, Di Giuseppe J, et al
    Detection of occult endocervical glandular dysplasia in cervical conization specimens for squamous lesions.
    Pathol Res Pract. 2017;213:210-216.
    Abstract    

    Abstract available

  78. SCRIVANO L, Iacopetta D, Sinicropi MS, Saturnino C, et al
    Synthesis of sericin-based conjugates by click chemistry: enhancement of sunitinib bioavailability and cell membrane permeation.
    Drug Deliv. 2017;24:482-490.
    Abstract    

    Abstract available

  79. HUA X, Yang Q, Dong Z, Zhang J, et al
    Magnetically triggered drug release from nanoparticles and its applications in anti-tumor treatment.
    Drug Deliv. 2017;24:511-518.
    Abstract    

    Abstract available

  80. YU Y, Xu S, You H, Zhang Y, et al
    In vivo synergistic anti-tumor effect of paclitaxel nanoparticles combined with radiotherapy on human cervical carcinoma.
    Drug Deliv. 2017;24:75-82.
    Abstract    

    Abstract available

  81. WU S, Yang X, Lu Y, Fan Z, et al
    A green approach to dual-drug nanoformulations with targeting and synergistic effects for cancer therapy.
    Drug Deliv. 2017;24:51-60.
    Abstract    

    Abstract available

  82. GAO G, Smith DI
    Role of the Common Fragile Sites in Cancers with a Human Papillomavirus Etiology.
    Cytogenet Genome Res. 2016;150.
    Abstract    

    Abstract available

  83. COLEMAN N
    Virus and Host Events in Squamous Carcinogenesis.
    Keio J Med. 2016;65:78.
    Abstract    

    Abstract available

  84. ZHANG W, He W, Shi Y, Zhao J, et al
    Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
    Int J Oncol. 2016 Nov 29. doi: 10.3892/ijo.2016.3784.
    Abstract    

    Abstract available

  85. ROSZAK A, Lutkowska A, Lianeri M, Sowinska A, et al
    Involvement of myeloperoxidase gene polymorphism 463G>A in development of cervical squamous cell carcinoma.
    Int J Biol Markers. 2016;31:e440-e445.
    Abstract    

    Abstract available

  86. ANDO H, Miyamoto T, Kashima H, Takatsu A, et al
    Usefulness of a management protocol for patients with cervical multicystic lesions: A retrospective analysis of 94 cases and the significance of GNAS mutation.
    J Obstet Gynaecol Res. 2016;42:1588-1598.
    Abstract    

    Abstract available

  87. SMITH M, Canfell K
    Impact of the Australian National Cervical Screening Program in women of different ages.
    Med J Aust. 2016;205:359-364.
    Abstract    

    Abstract available

  88. CARTER J
    The renewal of the National Cervical Screening Program.
    Med J Aust. 2016;205:357-358.
    Abstract    



  89. WANG HY, Yu HZ, Huang SM, Zheng YL, et al
    p53, Bcl-2 and cox-2 are involved in berberine hydrochloride-induced apoptosis of HeLa229 cells.
    Mol Med Rep. 2016;14:3855-61.
    Abstract    

    Abstract available

  90. GAO J, Fan L, Ma W, Xiao H, et al
    Synergistic antitumor effect of a human papillomavirus DNA vaccine harboring E6E7 fusion gene and vascular endothelial growth factor receptor 2 gene.
    Microbiol Immunol. 2016;60:626-33.
    Abstract    

    Abstract available

  91. ZHUANG QY, Wong RX, Chen WM, Guo XX, et al
    Knowledge, attitudes and practices regarding human papillomavirus vaccination among young women attending a tertiary institution in Singapore.
    Singapore Med J. 2016;57:329-33.
    Abstract    

    Abstract available

  92. AMYES E, Russell P, Chan F
    Cervical adenosquamous carcinoma with extension to uterine corpus.
    Pathology. 2016;48:521-3.
    Abstract    



  93. BISHERWAL K, Pandhi D, Singal A, Guleria K, et al
    Evaluation of cervical and anal intraepithelial neoplasia in women attending a sexually transmitted infection clinic.
    Indian J Dermatol Venereol Leprol. 2016;82:498-504.
    Abstract    

    Abstract available

  94. KARURI AR, Kashyap VK, Yallapu MM, Zafar N, et al
    Disparity in rates of HPV infection and cervical cancer in underserved US populations.
    Front Biosci (Schol Ed). 2017;9:254-269.
    Abstract    

    Abstract available

  95. SHEN WC, Chen SW, Liang JA, Hsieh TC, et al
    [18]Fluorodeoxyglucose Positron Emission Tomography for the Textural Features of Cervical Cancer Associated with Lymph Node Metastasis and Histological Type.
    Eur J Nucl Med Mol Imaging. 2017 Apr 14. doi: 10.1007/s00259-017-3697.
    Abstract    

    Abstract available

  96. ASHTARIAN H PHD, Mirzabeigi E Bs, Mahmoodi E Bs, Khezeli M PhD, et al
    Knowledge about Cervical Cancer and Pap Smear and the Factors Influencing the Pap test Screening among Women.
    Int J Community Based Nurs Midwifery. 2017;5:188-195.
    Abstract    

    Abstract available

  97. MBOUMBA BOUASSA RS, Prazuck T, Lethu T, Meye JF, et al
    Cervical cancer in sub-Saharan Africa: an emerging and preventable disease associated with oncogenic human papillomavirus.
    Med Sante Trop. 2017;27:16-22.
    Abstract    

    Abstract available

  98. LOPEZ CS, Krauskopf E, Villota CE, Burzio LO, et al
    Cervical cancer, human papillomavirus and vaccines: assessment of the information retrieved from general knowledge websites in Chile.
    Public Health. 2017;148:19-24.
    Abstract    

    Abstract available

  99. STEWART Z, Garcin E, Nazac A, Mezan de Malartic C, et al
    Organization and first results of cervical cancer screening program in Mayotte, from 2010 to 2014.
    J Gynecol Obstet Hum Reprod. 2017;46:125-130.
    Abstract    

    Abstract available

  100. HUANG HY, Tsai WC, Chou WY, Hung YC, et al
    Quality of life of breast and cervical cancer survivors.
    BMC Womens Health. 2017;17:30.
    Abstract    

    Abstract available

  101. SATO M, Kawana K, Adachi K, Fujimoto A, et al
    Regeneration of cervical reserve cell-like cells from human induced pluripotent stem cells (iPSCs): A new approach to finding targets for cervical cancer stem cell treatment.
    Oncotarget. 2017 Apr 3. doi: 10.18632/oncotarget.16783.
    Abstract    

    Abstract available

  102. SAHA SS, Chowdhury RR, Mondal NR, Roy S, et al
    Expression signatures of HOX cluster genes in cervical cancer pathogenesis: Impact of human papillomavirus type 16 oncoprotein E7.
    Oncotarget. 2017 Mar 28. doi: 10.18632/oncotarget.16619.
    Abstract    

    Abstract available

  103. HE A, Shao J, Zhang Y, Lu H, et al
    CD200Fc reduces LPS-induced IL-1beta activation in human cervical cancer cells by modulating TLR4-NF-kappaB and NLRP3 inflammasome pathway.
    Oncotarget. 2017 Mar 27. doi: 10.18632/oncotarget.16596.
    Abstract    

    Abstract available

  104. PHUAH NH, Azmi MN, Awang K, Nagoor NH, et al
    Down-Regulation of MicroRNA-210 Confers Sensitivity towards 1'S-1'-Acetoxychavicol Acetate (ACA) in Cervical Cancer Cells by Targeting SMAD4.
    Mol Cells. 2017 Apr 12. doi: 10.14348/molcells.2017.2285.
    Abstract    

    Abstract available

  105. KOSE MF, Kiseli M, Kimyon G, Ocalan R, et al
    Extraperitoneal lymph node dissection in locally advanced cervical cancer; the prognostic factors associated with survival.
    J Turk Ger Gynecol Assoc. 2017 Feb 7. doi: 10.4274/jtgga.2016.0202.
    Abstract    

    Abstract available

  106. XIONG Y, Sun F, Dong P, Watari H, et al
    iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling.
    J Exp Clin Cancer Res. 2017;36:48.
    Abstract    

    Abstract available

  107. IOFFE YJ, Massad LS, Powell MA, Hagemann AR, et al
    Survival of Cervical Cancer Patients Presenting with Occult Supraclavicular Metastases Detected by FDG-Positron Emission Tomography/CT: Impact of Disease Extent and Treatment.
    Gynecol Obstet Invest. 2017 Apr 8. doi: 10.1159/000458706.
    Abstract    

    Abstract available

  108. MEIJER CJ, Steenbergen RD
    Gynaecological cancer: Novel molecular subtypes of cervical cancer - potential clinical consequences.
    Nat Rev Clin Oncol. 2017 Apr 11. doi: 10.1038/nrclinonc.2017.
    Abstract    



  109. ACKERSON K, Stines Doane L
    Psychometric Testing of the Pap Smear Belief Questionnaire: Measuring Women's Attitudes and Beliefs Toward Cervical Cancer Screening.
    J Nurs Meas. 2017;25:77-89.
    Abstract    

    Abstract available

  110. KIM YK, Ham JY, Lee WK, Song KE, et al
    Spontaneous tumour lysis syndrome in cervical cancer.
    J Obstet Gynaecol. 2017 Apr 11:1-2. doi: 10.1080/01443615.2017.1299700.
    Abstract    



  111. LOWE NK
    Racial Disparity in the Prevalence of Cervical Cancer.
    J Obstet Gynecol Neonatal Nurs. 2017 Apr 6. pii: S0884-2175(17)30088.
    Abstract    



  112. DUBE MANDISHORA RS, Christiansen IK, Chin'ombe N, Duri K, et al
    Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe.
    J Med Virol. 2017 Apr 8. doi: 10.1002/jmv.24825.
    Abstract    

    Abstract available

  113. LI Y, Li S, Huang L
    Knockdown of Rap2B, a Ras Superfamily Protein, Inhibits Proliferation, Migration, and Invasion in Cervical Cancer Cells Via Regulating the ERK1/2 Signaling Pathway.
    Oncol Res. 2017 Apr 3. doi: 10.3727/096504017X14912172235777.
    Abstract    

    Abstract available

  114. VAN SN, Khac MN, Dimberg J, Matussek A, et al
    Prevalence of Cervical Infection and Genotype Distribution of Human Papilloma Virus Among Females in Da Nang, Vietnam.
    Anticancer Res. 2017;37:1243-1247.
    Abstract    

    Abstract available

  115. SINGH MP, Gupta N, Deepak T, Kumar A, et al
    Multiplex polymerase chain reaction for the detection of high-risk-human papillomavirus types in formalin-fixed paraffin-embedded cervical tissues.
    Indian J Med Microbiol. 2017;35:113-115.
    Abstract    

    Abstract available

  116. XIE S, Song L, Yang F, Tang C, et al
    Enhanced efficacy of adjuvant chemotherapy and radiotherapy in selected cases of surgically resected neuroendocrine carcinoma of the uterine cervix: A retrospective cohort study.
    Medicine (Baltimore). 2017;96:e6361.
    Abstract    

    Abstract available

  117. MUELLER JL, Asma E, Lam CT, Krieger MS, et al
    International Image Concordance Study to Compare a Point-of-Care Tampon Colposcope With a Standard-of-Care Colposcope.
    J Low Genit Tract Dis. 2017;21:112-119.
    Abstract    

    Abstract available

  118. ALADE RO, Vragovic O, Duffy C, Cabral HJ, et al
    Human Papillomavirus Co-Testing Results Effectively Triage Normal Cervical Cytology in HIV-Positive Women Aged 30 Years and Older.
    J Low Genit Tract Dis. 2017;21:125-128.
    Abstract    

    Abstract available

  119. CHEVREAU J, Mercuzot A, Foulon A, Attencourt C, et al
    Impact of Age at Conization on Obstetrical Outcome: A Case-Control Study.
    J Low Genit Tract Dis. 2017;21:97-101.
    Abstract    

    Abstract available

  120. KIETPEERAKOOL C, Chumworathayi B, Thinkhamrop J, Ussahgij B, et al
    Antibiotics for infection prevention after excision of the cervical transformation zone.
    Cochrane Database Syst Rev. 2017;1:CD009957.
    Abstract    

    Abstract available

  121. MOUKARZEL LA, Angarita AM, VandenBussche C, Rositch A, et al
    Preinvasive and Invasive Cervical Adenocarcinoma: Preceding Low-Risk or Negative Pap Result Increases Time to Diagnosis.
    J Low Genit Tract Dis. 2017;21:91-96.
    Abstract    

    Abstract available

  122. EL-NASHAR SA, Shazly SA, Hopkins MR, Bakkum-Gamez JN, et al
    Loop Electrosurgical Excision Procedure Instead of Cold-Knife Conization for Cervical Intraepithelial Neoplasia in Women With Unsatisfactory Colposcopic Examinations: A Systematic Review and Meta-Analysis.
    J Low Genit Tract Dis. 2017;21:129-136.
    Abstract    

    Abstract available

  123. CARCOPINO X, Mancini J, Prendiville W, Gondry J, et al
    The Accuracy of Large Loop Excision of the Transformation Zone Specimen Dimensions in Determining Volume: A Multicentric Prospective Observational Study.
    J Low Genit Tract Dis. 2017;21:120-124.
    Abstract    

    Abstract available

  124. HOQUE ME
    Factors influencing the recommendation of the Human Papillomavirus vaccine by South African doctors working in a tertiary hospital.
    Afr Health Sci. 2016;16:567-75.
    Abstract    

    Abstract available

  125. TWU NF, Ou YC, Liao CI, Chang WY, et al
    Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma/adenosquamous carcinoma after primary radical surgery: A Taiwanese Gynecologic Oncology Group (TGOG) study.
    Surg Oncol. 2016;25:229-35.
    Abstract    

    Abstract available

  126. BILIATIS I
    Pregnancy outcomes after treatment for preinvasive cervical lesions.
    BMJ. 2016;354:i4027.
    Abstract    



  127. GUAN S, Lu J, Zhao Y, Woodfield SE, et al
    TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis.
    Oncotarget. 2017 Apr 6. doi: 10.18632/oncotarget.16895.
    Abstract    

    Abstract available

  128. LIU Y, Tian M, Zhao H, He Y, et al
    IER5 as a promising predictive marker promotes irradiation-induced apoptosis in cervical cancer tissues from patients undergoing chemoradiotherapy.
    Oncotarget. 2017 Apr 5. doi: 10.18632/oncotarget.16857.
    Abstract    

    Abstract available

  129. LIN X, Wan N, Weng L, Zhou Y, et al
    Light scattering from normal and cervical cancer cells.
    Appl Opt. 2017;56:3608-3614.
    Abstract    

    Abstract available

  130. STELMA T, Leaner VD
    KPNB1-mediated nuclear import is required for motility and inflammatory transcription factor activity in cervical cancer cells.
    Oncotarget. 2017 Mar 2. doi: 10.18632/oncotarget.15834.
    Abstract    

    Abstract available

  131. WIJAYA AB, Hidayatullah F, Setyabudhi VV, Pahlevi FR, et al
    Profile of POT1 as telomerase shelterin component discriminatesbetween cervical cancer and normal cervical cells.
    Turk J Med Sci. 2017;47:417-423.
    Abstract    

    Abstract available

  132. SUROV A, Meyer HJ, Schob S, Hohn AK, et al
    Parameters of simultaneous 18F-FDG-PET/MRI predict tumor stage and several histopathological features in uterine cervical cancer.
    Oncotarget. 2017 Mar 9. doi: 10.18632/oncotarget.16043.
    Abstract    

    Abstract available

  133. HAN X, Wen H, Ju X, Chen X, et al
    Predictive factors of para-aortic lymph nodes metastasis in cervical cancer patients: a retrospective analysis based on 723 para-aortic lymphadenectomy cases.
    Oncotarget. 2017 Mar 8. doi: 10.18632/oncotarget.16025.
    Abstract    

    Abstract available

  134. FANG J, Li Y, Zhang J, Yan M, et al
    Correlation between polymorphisms in microRNA-regulated genes and cervical cancer susceptibility in a Xinjiang Uygur population.
    Oncotarget. 2017 Mar 7. doi: 10.18632/oncotarget.15970.
    Abstract    

    Abstract available

  135. HANPRASERTPONG J, Jiamset I
    Late Recurrence of Early Stage Cervical Cancer more than 3 Years after Radical Hysterectomy with Pelvic Node Dissection.
    Oncol Res Treat. 2017;40.
    Abstract    



  136. SEAY J, Ranck A, Weiss R, Salgado C, et al
    Understanding Transgender Men's Experiences with and Preferences for Cervical Cancer Screening: A Rapid Assessment Survey.
    LGBT Health. 2017 Apr 19. doi: 10.1089/lgbt.2016.0143.
    Abstract    

    Abstract available

  137. AL-SHAIKH GK, Syed SB, Fayed AA, Al-Shaikh RA, et al
    Effectiveness of health education programme: Level of knowledge about prevention of cervical cancer among Saudi female healthcare students.
    J Pak Med Assoc. 2017;67:513-520.
    Abstract    

    Abstract available

  138. WU CJ, Chang WC, Chen CH, Chen CA, et al
    Radical trachelectomy for early stage cervical cancer: A case series and literature review.
    Taiwan J Obstet Gynecol. 2017;56:143-146.
    Abstract    

    Abstract available

  139. ADEBAMOWO SN, Dareng EO, Famooto AO, Offiong R, et al
    Cohort Profile: African Collaborative Center for Microbiome and Genomics Research's (ACCME) Human Papillomavirus (HPV) and Cervical Cancer Study.
    Int J Epidemiol. 2017 Apr 13. doi: 10.1093.
    Abstract    



  140. ZHANG Q, Li W, Kanis MJ, Qi G, et al
    Oncologic and obstetrical outcomes with fertility-sparing treatment of cervical cancer: a systematic review and meta-analysis.
    Oncotarget. 2017 Mar 15. doi: 10.18632/oncotarget.16233.
    Abstract    

    Abstract available

  141. DAI L, Cao Y, Jiang W, Zabaleta J, et al
    KSHV co-infection down-regulates HPV16 E6 and E7 from cervical cancer cells.
    Oncotarget. 2017 Mar 15. doi: 10.18632/oncotarget.16207.
    Abstract    

    Abstract available

  142. LI K, Yin R, Wang D, Li Q, et al
    Human papillomavirus subtypes distribution among 2309 cervical cancer patients in West China.
    Oncotarget. 2017 Mar 10. doi: 10.18632/oncotarget.16093.
    Abstract    

    Abstract available

  143. GUO M, Zhao X, Yuan X, Jiang J, et al
    MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer.
    Oncotarget. 2017 Mar 8. doi: 10.18632/oncotarget.15999.
    Abstract    

    Abstract available

  144. AGGARWAL U, Goyal AK, Rath G
    Development and characterization of the cisplatin loaded nanofibers for the treatment of cervical cancer.
    Mater Sci Eng C Mater Biol Appl. 2017;75:125-132.
    Abstract    

    Abstract available

  145. JEONG H, Hong SR, Chae SW, Jin SY, et al
    Comparison of Unsatisfactory Samples from Conventional Smear versus Liquid-Based Cytology in Uterine Cervical Cancer Screening Test.
    J Pathol Transl Med. 2017 Apr 17. doi: 10.4132/jptm.2017.
    Abstract    

    Abstract available

  146. WANG B, Huang Z, Gao R, Zeng Z, et al
    Expression of Long Noncoding RNA Urothelial Cancer Associated 1 Promotes Cisplatin Resistance in Cervical Cancer.
    Cancer Biother Radiopharm. 2017;32:101-110.
    Abstract    

    Abstract available

  147. KISH JK, Rolin AI, Zou Z, Cucinelli JE, et al
    Prioritizing US Cervical Cancer Prevention With Results From a Geospatial Model.
    J Glob Oncol. 2016;2:275-283.
    Abstract    

    Abstract available

  148. JAMES M, Thomas M, Frolov L, Riano NS, et al
    Rates of Cervical Cancer Screening Among Women With Severe Mental Illness in the Public Health System.
    Psychiatr Serv. 2017 Apr 17:appips201600293. doi: 10.1176/appi.ps.201600293.
    Abstract    

    Abstract available

  149. WANG C, Cheng H, Li Y
    Role of SDF-1 and CXCR4 in the proliferation, migration and invasion of cervical cancer.
    Pak J Pharm Sci. 2016;29.
    Abstract    

    Abstract available

  150. PANAGOPOULOU M, Lambropoulou M, Balgkouranidou I, Nena E, et al
    Gene promoter methylation and protein expression of BRMS1 in uterine cervix in relation to high-risk human papilloma virus infection and cancer.
    Tumour Biol. 2017;39:1010428317697557.
    Abstract    

    Abstract available

  151. NARULA N, Steinhart AH
    Preventive care for a 35-year-old woman with inflammatory bowel disease.
    CMAJ. 2017;189:E243-E244.
    Abstract    



  152. BATISTA JE, Saddi VA, Carvalho KP, Ribeiro AA, et al
    Human papillomavirus genotypes 68 and 58 are the most prevalent genotypes in women from quilombo communities in the state of Maranhao, Brazil.
    Int J Infect Dis. 2017;55:51-55.
    Abstract    

    Abstract available

  153. MITILDZANS A, Arechvo A, Rezeberga D, Isajevs S, et al
    Expression of p63, p53 and Ki-67 in Patients with Cervical Intraepithelial Neoplasia.
    Turk Patoloji Derg. 2017;33:9-16.
    Abstract    

    Abstract available

  154. CHAO WR, Chen CK, Han LM, Han CP, et al
    Mutation-free expression of c-Kit proto-oncogene in primary adenocarcinoma of uterine cervix.
    Taiwan J Obstet Gynecol. 2016;55:741-742.
    Abstract    



  155. BAE SJ, Lee DS, Berezin V, Kang U, et al
    Multispectral autofluorescence imaging for detection of cervical lesions: A preclinical study.
    J Obstet Gynaecol Res. 2016;42:1846-1853.
    Abstract    

    Abstract available

  156. CHEN K, Ouyang Y, Hillemanns P, Jentschke M, et al
    Excellent analytical and clinical performance of a dry self-sampling device for human papillomavirus detection in an urban Chinese referral population.
    J Obstet Gynaecol Res. 2016;42:1839-1845.
    Abstract    

    Abstract available

  157. YUAN ZX, Ma TH, Wang HM, Zhong QH, et al
    Colostomy is a simple and effective procedure for severe chronic radiation proctitis.
    World J Gastroenterol. 2016;22:5598-608.
    Abstract    

    Abstract available

  158. HSU LC, Lin JC, Ho SP
    A case of lymphoepithelioma-like carcinoma of the uterine cervix in a patient with a history of high-grade squamous intraepithelial lesion.
    Taiwan J Obstet Gynecol. 2016;55:453-4.
    Abstract    



  159. RIBEIRO L, Bastos RR, Vieira Mde T, Ribeiro LC, et al
    [Opportunistic screening versus missed opportunities: non-adherence to Pap smear testing in women attending prenatal care].
    Cad Saude Publica. 2016;32.
    Abstract    

    Abstract available

  160. CAPPIELLO J, Levi A
    The Annual Gynecologic Examination Updated for the 21st Century.
    Nurs Womens Health. 2016;20:315-9.
    Abstract    

    Abstract available

  161. ZHAO X, Tao X, Xu L, Yin L, et al
    Dioscin Induces Apoptosis in Human Cervical Carcinoma HeLa and SiHa Cells through ROS-Mediated DNA Damage and the Mitochondrial Signaling Pathway.
    Molecules. 2016;21.
    Abstract    

    Abstract available

  162. HAJMOHAMMADI S, Rassi H
    Cloning and Expression of L1 Protein Human Papillomavirus Type 31 Isolated from Iranian Patients in Escherichia coli.
    Monoclon Antib Immunodiagn Immunother. 2016;35:181-5.
    Abstract    

    Abstract available

  163. MUNRO A, Codde J, Spilsbury K, Stewart CJ, et al
    Risk of persistent or recurrent neoplasia in conservatively treated women with cervical adenocarcinoma in situ with negative histological margins.
    Acta Obstet Gynecol Scand. 2017;96:432-437.
    Abstract    

    Abstract available

  164. VIVIANO M, Catarino R, Jeannot E, Boulvain M, et al
    Self-sampling to improve cervical cancer screening coverage in Switzerland: a randomised controlled trial.
    Br J Cancer. 2017 Apr 20. doi: 10.1038/bjc.2017.
    Abstract    

    Abstract available

  165. BERMAN TA, Schiller JT
    Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
    Cancer. 2017 Mar 27. doi: 10.1002/cncr.30588.
    Abstract    

    Abstract available

  166. ALSBEIH GA, Al-Harbi NM, Bin Judia SS, Khoja HA, et al
    Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence.
    Cancer. 2017 Apr 10. doi: 10.1002/cncr.30635.
    Abstract    

    Abstract available

  167. MUNAKATA S, Sasaki S, Takase M, Okatake R, et al
    Practical usefulness of atypical endometrial cell categories within the new classification of endometrial cytology when applied to conventional smears.
    Cytopathology. 2017;28:131-139.
    Abstract    

    Abstract available

  168. KIR G, Sarbay BC, Seneldir H
    The significance of parakeratosis alone in cervicovaginal cytology of turkish women.
    Diagn Cytopathol. 2017;45:297-302.
    Abstract    

    Abstract available

  169. LYNGE E, Lonnberg S, Tornberg S
    Cervical cancer incidence in elderly women-biology or screening history?
    Eur J Cancer. 2017;74:82-88.
    Abstract    

    Abstract available

  170. TORKY HA
    Huge Nabothian cyst causing Hematometra (case report).
    Eur J Obstet Gynecol Reprod Biol. 2016;207:238-240.
    Abstract    



  171. SURBONE A, Achtari C
    Embryonal rhabdomyosarcoma in a child exposed to chemotherapy in utero: a mere coincidence?
    Eur J Obstet Gynecol Reprod Biol. 2016;207:235.
    Abstract    



  172. GARUTTI P, Cristiani P, Fantin GP, Sopracordevole F, et al
    Interpretation of colposcopy in population-based cervical screening services in north-eastern Italy: an online interregional agreement study.
    Eur J Obstet Gynecol Reprod Biol. 2016;206:64-69.
    Abstract    

    Abstract available

  173. JANCAR N, Mihevc Ponikvar B, Tomsic S
    Cold-knife conisation and large loop excision of transformation zone significantly increase the risk for spontaneous preterm birth: a population-based cohort study.
    Eur J Obstet Gynecol Reprod Biol. 2016;203:245-9.
    Abstract    

    Abstract available

  174. MCCARTHY CM, Ramphul M, Madden M, Hickey K, et al
    The use and success of cold coagulation for the treatment of high grade squamous cervical intra-epithelial neoplasia: a retrospective review.
    Eur J Obstet Gynecol Reprod Biol. 2016;203:225-8.
    Abstract    

    Abstract available

  175. BAIOCCHI G, de Brot L, Faloppa CC, Mantoan H, et al
    Is parametrectomy always necessary in early-stage cervical cancer?
    Gynecol Oncol. 2017 Apr 6. pii: S0090-8258(17)30769.
    Abstract    

    Abstract available

  176. BALTZER N, Sundstrom K, Nygard JF, Dillner J, et al
    Risk Stratification in Cervical Cancer Screening by Complete Screening History- Applying Bioinformatics to a General Screening Population.
    Int J Cancer. 2017 Apr 6. doi: 10.1002/ijc.30725.
    Abstract    

    Abstract available

  177. KONERU A, Jolly PE, Blakemore S, McCree R, et al
    Acceptance of peer navigators to reduce barriers to cervical cancer screening and treatment among women with HIV infection in Tanzania.
    Int J Gynaecol Obstet. 2017 Apr 8. doi: 10.1002/ijgo.12174.
    Abstract    

    Abstract available

  178. ZHANG Y, Gao H, Gao X, Huang S, et al
    Elevated Expression of Kin17 in Cervical Cancer and Its Association With Cancer Cell Proliferation and Invasion.
    Int J Gynecol Cancer. 2017 Mar 24. doi: 10.1097/IGC.0000000000000928.
    Abstract    

    Abstract available

  179. WANG Q, Wei Y, Zhang J
    Combined Knockdown of D-dopachrome Tautomerase and Migration Inhibitory Factor Inhibits the Proliferation, Migration, and Invasion in Human Cervical Cancer.
    Int J Gynecol Cancer. 2017 Mar 23. doi: 10.1097/IGC.0000000000000951.
    Abstract    

    Abstract available

  180. OUYANG F, Liu J, Xia M, Lin C, et al
    GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer.
    Oncol Rep. 2017;37:2652-2662.
    Abstract    

    Abstract available

  181. LI W, Liang J, Zhang Z, Lou H, et al
    MicroRNA-329-3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer.
    Oncol Rep. 2017;37:2743-2750.
    Abstract    

    Abstract available

  182. PANG X, Zhang Y, Zhang S
    High-mobility group box 1 is overexpressed in cervical carcinoma and promotes cell invasion and migration in vitro.
    Oncol Rep. 2017;37:831-840.
    Abstract    

    Abstract available

  183. MENDEZ LC, Weiss Y, D'Souza D, Ravi A, et al
    Three-dimensional-guided perineal-based interstitial brachytherapy in cervical cancer: A systematic review of technique, local control and toxicities.
    Radiother Oncol. 2017 Mar 25. pii: S0167-8140(17)30101.
    Abstract    

    Abstract available

  184. VAN HEERDEN LE, Houweling AC, Koedooder K, van Kesteren Z, et al
    Structure-based deformable image registration: Added value for dose accumulation of external beam radiotherapy and brachytherapy in cervical cancer.
    Radiother Oncol. 2017 Mar 31. pii: S0167-8140(17)30111.
    Abstract    

    Abstract available

  185. LI X
    Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancer.
    BMC Cancer. 2017;17:252.
    Abstract    

    Abstract available

  186. GAO Q, Lin S, Bai P, Du M, et al
    FZUImageReg: A toolbox for medical image registration and dose fusion in cervical cancer radiotherapy.
    PLoS One. 2017;12:e0174926.
    Abstract    

    Abstract available

  187. LABEIT AM, Peinemann F
    Determinants of a GP visit and cervical cancer screening examination in Great Britain.
    PLoS One. 2017;12:e0174363.
    Abstract    

    Abstract available

  188. NAWALE L, Dubey P, Chaudhari B, Sarkar D, et al
    Anti-proliferative effect of novel primary cetyl alcohol derived sophorolipids against human cervical cancer cells HeLa.
    PLoS One. 2017;12:e0174241.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;